专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US12093681B2 Ambulatory medicament device with security override passcode 有权
公开(公告)号：US12093681B2
公开(公告)日：2024-09-17
申请号：US17486784
申请日：2021-09-27
申请人： Beta Bionics, Inc.
发明人： Michael J. Rosinko , Himanshu Patel , Edward R. Damiano , Firas H. El-Khatib
IPC分类号： A61M5/172 , A61M5/142 , A61M5/168 , G06F3/04847 , G06F3/04883 , G06F8/61 , G06F8/65 , G06F8/656 , G06F21/30 , G06F21/31 , G06F21/62 , G06F21/84 , G08B21/04 , G08B21/18 , G16H10/60 , G16H20/17 , G16H40/40 , G16H40/60 , G16H40/67 , G16H50/30 , G16H80/00 , H04L9/08 , H04L9/30 , H04L9/40 , H04L67/00 , H04W76/10 , H04W76/14 , A61B5/145 , G08B25/00 , G16H40/00
CPC分类号： G06F8/656 , A61M5/142 , A61M5/14244 , A61M5/14248 , A61M5/16831 , A61M5/172 , G06F3/04847 , G06F3/04883 , G06F8/61 , G06F8/65 , G06F21/305 , G06F21/31 , G06F21/6245 , G06F21/84 , G08B21/0453 , G08B21/18 , G16H10/60 , G16H20/17 , G16H40/40 , G16H40/60 , G16H40/67 , G16H50/30 , G16H80/00 , H04L9/088 , H04L9/30 , H04L63/101 , H04L67/34 , H04W76/10 , H04W76/14 , A61B5/14532 , A61M2005/14208 , A61M5/1723 , A61M2005/1726 , A61M2205/18 , A61M2205/3327 , A61M2205/3546 , A61M2205/3553 , A61M2205/3584 , A61M2205/3592 , A61M2205/50 , A61M2205/502 , A61M2205/505 , A61M2205/52 , A61M2205/581 , A61M2205/582 , A61M2205/583 , A61M2205/609 , A61M2230/201 , G08B25/00 , G16H40/00
摘要： An ambulatory medicament device can generate a dose control signal for delivery of medicament to a subject and secure at least some functionality of a user interface of the ambulatory medicament device. The ambulatory medicament device can have a locked state that restricts modification of at least one control parameter. The ambulatory medicament device can have an unlocked state that allows modification of at least one control parameter. The ambulatory medicament device can accept a user input of a security code that is validated against a passcode to enter from the locked state to the unlocked state.

2. 外观设计

USD1032623S1 Display screen with animated graphical user interface 有权
公开(公告)号：USD1032623S1
公开(公告)日：2024-06-25
申请号：US29776041
申请日：2021-03-26
申请人： Beta Bionics, Inc.
设计人： David Chi-Wai Lim , Edward R. Damiano , Michael J. Rosinko , Mads Henrik Dall
摘要： This invention was made with U.S. Government support under Agreement No. W912CG20C0013, awarded by Defense Advanced Research Projects Agency. The Government has certain rights in the invention.
FIG. 1 is a front view of a first image of a first embodiment of a display screen with animated graphical user interface embodying the new design;
FIG. 2 is a front view of a second image thereof;
FIG. 3 is a front view of a third image thereof;
FIG. 4 is a front view of a fourth image thereof;
FIG. 5 is a front view of a fifth image thereof;
FIG. 6 is a front view of a sixth image thereof;
FIG. 7 is a front view of a seventh image thereof;
FIG. 8 is a front view of an eighth image thereof;
FIG. 9 is a front view of a ninth image thereof;
FIG. 10 is a front view of a tenth image thereof;
FIG. 11 is a front view of an eleventh image thereof; and
FIG. 12 is a front view of a twelfth image thereof.
FIG. 12 is a front view of a first image of a second embodiment of a display screen with animated graphical user interface embodying the new design;
FIG. 11 is a front view of a second image thereof;
FIG. 10 is a front view of a third image thereof;
FIG. 9 is a front view of a fourth image thereof;
FIG. 8 is a front view of a fifth image thereof;
FIG. 7 is a front view of a sixth image thereof;
FIG. 6 is a front view of a seventh image thereof;
FIG. 5 is a front view of an eighth image thereof;
FIG. 4 is a front view of a ninth image thereof;
FIG. 3 is a front view of a tenth image thereof;
FIG. 2 is a front view of an eleventh image thereof; and,
FIG. 1 is a front view of a twelfth image thereof.
The broken line showing of a display screen with graphical user interface is included for the purpose of showing portions of the article which form no part of the claim.
The appearance of the transitional image of a first embodiment of the claimed design sequentially transitions between the images shown in FIGS. 1-12. The appearance of the transitional image of a second embodiment of the claimed design sequentially transitions between the images shown in FIGS. 12-1. The process or period in which one image transitions to another image forms no part of the claimed design.

3. 发明授权

US11957876B2 Glucose control system with automated backup therapy protocol generation 有权
公开(公告)号：US11957876B2
公开(公告)日：2024-04-16
申请号：US17212984
申请日：2021-03-25
申请人： BETA BIONICS, INC.
发明人： Edward B. Raskin , David Chi-Wai Lim , Michael J. Rosinko , Firas H. El-Khatib , Edward R. Damiano
IPC分类号： A61M5/172
CPC分类号： A61M5/1723 , A61M2205/52 , A61M2230/201
摘要： An automated blood glucose control system is configured to generate a backup therapy protocol comprising insulin therapy instructions derived from autonomously determined doses of insulin. The system generates a dose control signal using a control algorithm configured to autonomously determine doses of insulin to be infused into a subject for the purpose of controlling blood glucose of the subject based at least in part on a glucose level signal received from a glucose sensor. The system can track insulin therapy administered to the subject over a tracking period, including storing an indication of the autonomously determined doses of insulin delivered to the subject as basal insulin, as correction boluses of insulin, or as mealtime boluses of insulin. The system can generate a backup injection therapy protocol or a backup pump therapy protocol with insulin therapy instructions based at least in part on the insulin therapy administered to the subject over the tracking period.

4. 发明授权

US11803367B2 Ambulatory medicament device with alarm 有权
公开(公告)号：US11803367B2
公开(公告)日：2023-10-31
申请号：US17486436
申请日：2021-09-27
申请人： Beta Bionics, Inc.
发明人： Michael J. Rosinko , Edward R. Damiano , David Chi-Wai Lim , Firas H. El-Khatib , Justin P. Brown , Bryan Dale Knodel , Himanshu Patel
IPC分类号： G06F8/656 , G16H20/17 , G16H40/40 , H04W76/10 , A61M5/142 , A61M5/172 , G06F8/61 , H04L67/00 , G16H40/60 , G16H80/00 , A61M5/168 , G08B21/04 , G08B21/18 , G16H40/67 , G06F21/30 , G06F21/31 , G06F21/62 , G06F21/84 , G16H10/60 , G16H50/30 , G06F3/04883 , G06F8/65 , H04L9/40 , H04W76/14 , H04L9/08 , H04L9/30 , G06F3/04847 , G08B25/00 , A61B5/145 , G16H40/00
CPC分类号： G06F8/656 , A61M5/142 , A61M5/14244 , A61M5/14248 , A61M5/16831 , A61M5/172 , G06F3/04847 , G06F3/04883 , G06F8/61 , G06F8/65 , G06F21/305 , G06F21/31 , G06F21/6245 , G06F21/84 , G08B21/0453 , G08B21/18 , G16H10/60 , G16H20/17 , G16H40/40 , G16H40/60 , G16H40/67 , G16H50/30 , G16H80/00 , H04L9/088 , H04L9/30 , H04L63/101 , H04L67/34 , H04W76/10 , H04W76/14 , A61B5/14532 , A61M5/1723 , A61M2005/14208 , A61M2005/1726 , A61M2205/18 , A61M2205/3327 , A61M2205/3546 , A61M2205/3553 , A61M2205/3584 , A61M2205/3592 , A61M2205/50 , A61M2205/502 , A61M2205/505 , A61M2205/52 , A61M2205/581 , A61M2205/582 , A61M2205/583 , A61M2205/609 , A61M2230/201 , G08B25/00 , G16H40/00
摘要： Systems and methods are disclosed herein for monitoring the status of an ambulatory medical device and the health condition of a subject that receives therapy from the ambulatory medical device. The ambulatory medical device can have a touchscreen display user interface to receive input signals from a user and display alarm conditions associated with the status of an ambulatory medical device or health condition of a subject. The disclosed methods and systems can determine whether status information received from a monitoring system interface satisfies an alarm condition for the ambulatory medicament device or for the subject. If the status information satisfies an alarm condition, the touchscreen user interface can display one or more alarm status indicators corresponding to the alarm condition. The user can activate a therapy change interface on the touchscreen display and modify a control parameter of the ambulatory medical device that controls the therapy delivery to the subject.

5. 发明授权

US11768676B2 Switching blood glucose control system execution without interruption of therapy delivery 有权
公开(公告)号：US11768676B2
公开(公告)日：2023-09-26
申请号：US17478146
申请日：2021-09-17
申请人： Beta Bionics, Inc.
发明人： Michael J. Rosinko , Edward R. Damiano , David Chi-Wai Lim , Firas H. El-Khatib , Himanshu Patel , John R. Costik , Justin P. Brown , Bryan Dale Knodel
IPC分类号： G06F8/656 , G16H20/17 , G16H40/40 , H04W76/10 , A61M5/142 , A61M5/172 , G06F8/61 , H04L67/00 , G16H40/60 , G16H80/00 , A61M5/168 , G08B21/04 , G08B21/18 , G16H40/67 , G06F21/30 , G06F21/31 , G06F21/62 , G06F21/84 , G16H10/60 , G16H50/30 , G06F3/04883 , G06F8/65 , H04L9/40 , H04W76/14 , H04L9/08 , H04L9/30 , G06F3/04847 , G08B25/00 , A61B5/145 , G16H40/00
CPC分类号： G06F8/656 , A61M5/142 , A61M5/14244 , A61M5/14248 , A61M5/16831 , A61M5/172 , G06F3/04847 , G06F3/04883 , G06F8/61 , G06F8/65 , G06F21/305 , G06F21/31 , G06F21/6245 , G06F21/84 , G08B21/0453 , G08B21/18 , G16H10/60 , G16H20/17 , G16H40/40 , G16H40/60 , G16H40/67 , G16H50/30 , G16H80/00 , H04L9/088 , H04L9/30 , H04L63/101 , H04L67/34 , H04W76/10 , H04W76/14 , A61B5/14532 , A61M5/1723 , A61M2005/14208 , A61M2005/1726 , A61M2205/18 , A61M2205/3327 , A61M2205/3546 , A61M2205/3553 , A61M2205/3584 , A61M2205/3592 , A61M2205/50 , A61M2205/502 , A61M2205/505 , A61M2205/52 , A61M2205/581 , A61M2205/582 , A61M2205/583 , A61M2205/609 , A61M2230/201 , G08B25/00 , G16H40/00
摘要： Systems and methods are disclosed herein for switching control of an ambulatory medical device from an application executing on the ambulatory medical device to a safe version or a new version of the application without interrupting therapy provided by the ambulatory medical device to a subject. The ambulatory medical device can maintain copies of a safe version and a new version of the application. The disclosed systems and methods can execute the new version, while the prior version of the application continues to execute, determine whether a minimum set of operating conditions are satisfied by the new version, and switch control of the ambulatory medical device from the prior version to the new version. The systems and methods can also automatically revert to the safe version of the application case the current version is malfunctioning without interrupting therapy provided to the subject.

6. 发明授权

US11688501B2 Ambulatory medicament pump with safe access control 有权
公开(公告)号：US11688501B2
公开(公告)日：2023-06-27
申请号：US17653116
申请日：2022-03-01
申请人： Beta Bionics, Inc.
发明人： Michael J. Rosinko , Edward R. Damiano , Himanshu Patel , Firas H. El-Khatib , Robert James LeBourdais
IPC分类号： A61M5/172 , G16H20/17 , A61M5/142 , H04W4/80 , G16H40/60 , G16H50/50 , G16H40/67 , G06F21/31 , G16H20/60 , G06F21/34 , G16H50/20 , G16H40/63 , A61B5/145 , A61B5/00
CPC分类号： G16H20/17 , A61B5/14532 , A61B5/4839 , A61M5/14244 , A61M5/14248 , A61M5/172 , A61M5/1723 , G06F21/31 , G06F21/34 , G16H20/60 , G16H40/60 , G16H40/63 , G16H40/67 , G16H50/20 , G16H50/50 , H04W4/80 , A61M2005/14208 , A61M2005/14252 , A61M2005/14268 , A61M2005/1726 , A61M2205/18 , A61M2205/3386 , A61M2205/3553 , A61M2205/3569 , A61M2205/3584 , A61M2205/3592 , A61M2205/502 , A61M2205/505 , A61M2205/52 , A61M2205/609 , A61M2205/8206 , A61M2230/201 , A61M2230/63 , G06F2221/2137 , G06F2221/2141
摘要： Systems and methods are disclosed herein for managing access to therapy controls of an ambulatory medicament pump that provides therapy to a subject using safe access levels associated with the therapy controls. The therapy change controls may enable modification of the corresponding therapy control parameters. The disclosed systems and methods can determine the eligibility of a subject receiving therapy from the ambulatory medicament pump or a user of the ambulatory medicament pump, for a safe access level and provide access to the corresponding therapy change controls. The ambulatory medicament pump may provide access to the therapy change controls upon receiving an access signal. In some cases, the ambulatory medicament pump may receive a time-based passcode and provide access to the therapy change controls upon receiving a matching passcode from the user.

7. 发明授权

US11679201B2 Blood glucose control system with carbohydrate therapy indication 有权
公开(公告)号：US11679201B2
公开(公告)日：2023-06-20
申请号：US17349219
申请日：2021-06-16
申请人： BETA BIONICS, INC.
发明人： Firas H. El-Khatib , Edward R. Damiano
IPC分类号： A61M5/172 , G16H20/17 , G16H10/40 , G16H40/67 , A61M5/142 , G16H20/60
CPC分类号： A61M5/1723 , A61M5/14244 , G16H10/40 , G16H20/17 , G16H20/60 , G16H40/67 , A61M2005/14208 , A61M2005/1726 , A61M2205/16 , A61M2205/3553 , A61M2205/3561 , A61M2205/3584 , A61M2205/3592 , A61M2205/50 , A61M2205/502 , A61M2205/505 , A61M2205/52 , A61M2230/201
摘要： A blood glucose control system can generate an indication of total carbohydrate therapy over a period during use by a subject. The system can be connected to a medicament pump configured to deliver insulin therapy, other types of medicament therapy, or a combination of medicament therapies to the subject. The system can determine an amount of a counter-regulatory agent to respond to an impending risk of hypoglycemia or an episode of hypoglycemia and determine a dose of carbohydrate therapy based at least in part on the amount of the counter-regulatory agent. The system can track determined doses of carbohydrate therapy to generate the indication of total carbohydrate therapy over the period.

8. 发明授权

US11565041B2 Ambulatory medicament device with power saving mode 有权
公开(公告)号：US11565041B2
公开(公告)日：2023-01-31
申请号：US17685170
申请日：2022-03-02
申请人： Beta Bionics, Inc.
发明人： Himanshu Patel , Justin P. Brown
IPC分类号： A61M5/172 , A61M5/168 , G06F3/041 , A61M5/142 , G06F3/04883 , G06F3/16 , A61B5/00 , A61B5/145 , G08B21/02 , G08B21/18 , G08B23/00 , G08B25/01
摘要： Ambulatory medicament devices that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and methods can implement one or more features that improve the user experience, by modifying delivery of therapy to a subject after determining that a possible occlusion exists in a medicament delivery system, monitoring the status of an ambulatory medical device and the health condition of a subject that receives therapy from the ambulatory medical device and annunciating alarm condition when necessary, selectively muting alarm annunciations while a Do Not Disturb mode is activated, implementing various power saving modes to save power, controlling operation of the device and medicament delivery based on the user gesture controls, and controlling medicament delivery based on a condition of the ambulatory medicament device.

9. 发明授权

US11497852B2 Ambulatory medicament device with power saving mode 有权
公开(公告)号：US11497852B2
公开(公告)日：2022-11-15
申请号：US17685292
申请日：2022-03-02
申请人： Beta Bionics, Inc.
发明人： Himanshu Patel , Justin P. Brown
IPC分类号： G08B19/00 , A61M5/172 , A61M5/142
摘要： Ambulatory medicament devices that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and methods can implement one or more features that improve the user experience, by modifying delivery of therapy to a subject after determining that a possible occlusion exists in a medicament delivery system, monitoring the status of an ambulatory medical device and the health condition of a subject that receives therapy from the ambulatory medical device and annunciating alarm condition when necessary, selectively muting alarm annunciations while a Do Not Disturb mode is activated, implementing various power saving modes to save power, controlling operation of the device and medicament delivery based on the user gesture controls, and controlling medicament delivery based on a condition of the ambulatory medicament device.

10. 发明申请

US20220305202A1 CLOUD-CONNECTED AMBULATORY PUMP INTEGRATION 有权
公开(公告)号：US20220305202A1
公开(公告)日：2022-09-29
申请号：US17657086
申请日：2022-03-29
申请人： Beta Bionics, Inc.
发明人： Michael J. Rosinko , Himanshu Patel , Edward R. Damiano , Firas H. El-Khatib
IPC分类号： A61M5/172 , G06Q30/06 , G06Q20/10
摘要： Ambulatory medical devices, which includes ambulatory medicament pumps, and blood glucose control systems that provide therapy to a subject, such as blood glucose control, are disclosed. Disclosed systems and devices can implement one or more features that improve the user experience, such as prompting and/or facilitating the user to order additional infusion sets, sensors, and/or other components to facilitate treatment.

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式